Peripherally Inserted Central Catheter-Related Vein Thrombosis in Patients with Lung Cancer

Clinical and Applied Thrombosis/Hemostasis

Volumn 23, Issue 2, 2017, Pages 181-186

  Kang, Jun Ren ^a   Long, Li Hai ^a   Yan, Sun Wen ^a   Wei, Wang Wei ^a   Jun, Han Zhi ^a   Chen, Wei ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

central venous catheter thrombosis; chemotherapy; lung cancer; upper extremity deep vein thrombosis; venous thromboembolism

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; PACLITAXEL; VINORELBINE TARTRATE; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER STAGING; COHORT ANALYSIS; DIABETES MELLITUS; DRUG EXPOSURE; ECHOGRAPHY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; ISCHEMIC HEART DISEASE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UPPER EXTREMITY VENOUS THROMBOSIS; VENOUS THROMBOEMBOLISM; ADVERSE EFFECTS; CENTRAL VENOUS CATHETERIZATION; COMPLICATION; LUNG NEOPLASMS; MIDDLE AGED; RISK FACTOR; STATISTICAL MODEL; VENOUS THROMBOSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CATHETERIZATION, CENTRAL VENOUS; COHORT STUDIES; ETOPOSIDE; FEMALE; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; VENOUS THROMBOSIS;

EID: 85011635969     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029615595880     Document Type: Article

References (37)

1. Yusuf HR, Reyes N, Zhang QC, Okoroh EM, Siddiqi AE, Tsai J,. Hospitalizations of adults ≥60 years of age with venous thromboembolism. Clin Appl Thromb Hemost. 2014; 20 (2): 136-142.
2. Sivaslioglu S, Gursel T, Kocak U, Kaya Z,. The risk factors for thrombosis in children with acute lymphoblastic leukemia. Clin Appl Thromb Hemost. 2014; 20 (6): 651-653.
3. Chopra V, Anand S, Hickner A, et al. Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis. Lancet. 2013; 382 (9889): 311-325.
4. Ahn DH, Illum HB, Wang DH, Sharma A, Dowell JE,. Upper extremity venous thrombosis in patients with cancer with peripherally inserted central venous catheters: a retrospective analysis of risk factors. J Oncol Pract. 2013; 9 (1): e8-e12.
5. Boersma RS, Hamulyak K, Cate HT, Schouten HC,. Congenital thrombophilia and central venous catheter-related thrombosis in patients with cancer. Clin Appl Thromb Hemost. 2010; 16 (6): 643-649.
6. Williams V, Griffiths AB, Yap ZL, et al. Increased thrombophilic tendency in pediatric cystic fibrosis patients. Clin Appl Thromb Hemost. 2010; 16 (1): 71-76.
7. Lobo BL, Vaidean G, Broyles J, Reaves AB, Shorr RI,. Risk of venous thromboembolism in hospitalized patients with peripherally inserted central catheters. J Hosp Med. 2009; 4 (7): 417-422.
8. Saber W, Moua T, Williams EC, et al. Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies. J Thromb Haemost. 2011; 9 (2): 312-319.
9. Lee AY, Kamphuisen PW,. Epidemiology and prevention of catheter-related thrombosis in patients with cancer. J Thromb Haemost. 2012; 10 (8): 1491-149.
10. Tafur AJ, Kalsi H, Wysokinski WE, et al. The association of active cancer with venous thromboembolism location: a population-based study. Mayo Clin Proc. 2011; 86 (1): 25-30.
11. Arslan S, Manduz S, Epöztürk K, Karahan O, Akkurt I,. Association of deep venous thrombosis with prothrombotic gene polymorphism identified in lung cancer cases. Mol Biol Rep. 2011; 38 (4): 2395-2400.
12. Connolly GC, Menapace L, Safadjou S, Francis CW, Khorana AA,. Prevalence and clinical significance of incidental and clinically suspected venous thromboembolism in lung cancer patients. Clin Lung Cancer. 2013; 14 (6): 713-718.
13. Hicks LK, Cheung MC, Ding K, et al. Venous thromboembolism and nonsmall cell lung cancer: a pooled analysis of National Cancer Institute of Canada Clinical Trials Group trials. Cancer. 2009; 115 (23): 5516-5525.
14. Connolly GC, Dalal M, Lin J, Khorana AA,. Incidence and predictors of venous thromboembolism (VTE) among ambulatory patients with lung cancer. Lung Cancer. 2012; 78 (3): 253-258.
15. Gabriel F, Portolés O, Labiós M, et al. Usefulness of thrombophilia testing in venous thromboembolic disease: findings from the RIETE registry. Clin Appl Thromb Hemost. 2013; 19 (1): 42-47.
16. Verso M, Agnelli G, Kamphuisen PW, et al. Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients. Intern Emerg Med. 2008; 3 (2): 117-122.
17. Verso M, Gussoni G, Agnelli G,. Prevention of venous thromboembolism in patients with advanced lung cancer receiving chemotherapy: a combined analysis of the PROTECHT and TOPIC-2 studies. J Thromb Haemost. 2010; 8 (7): 1649-1651.
18. Corrales-Rodriguez L, Blais N,. Lung cancer associated venous thromboembolic disease: a comprehensive review. Lung Cancer. 2012; 75 (1): 1-8.
19. Lin J, Wakefield TW, Henke PK,. Risk factors associated with venous thromboembolic events in patients with malignancy. Blood Coagul Fibrinolysis. 2006; 17 (4): 265-270.
20. Piran S, Ngo V, McDiarmid S, Le Gal G, Petrcich W, Carrier M,. Incidence and risk factors of symptomatic venous thromboembolism related to implanted ports in cancer patients. Thromb Res. 2014; 133 (1): 30-33
21. Moore RA, Adel N, Riedel E, et al. High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis. J Clin Oncol. 2011; 29 (25): 3466-3473.
22. Numico G, Garrone O, Dongiovanni V, et al. Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine. Cancer. 2005; 103 (5): 994-999.
23. Tesselaar ME, Ouwerkerk J, Nooy MA, Rosendaal FR, Osanto S,. Risk factors for catheter-related thrombosis in cancer patients. Eur J Cancer. 2004; 40 (15): 2253-2259.
24. Liem TK, Yanit KE, Moseley SE, et al. Peripherally inserted central catheter usage patterns and associated symptomatic upper extremity venous thrombosis. J Vasc Surg. 2012; 55 (3): 761-767.
25. Chopra V, Ratz D, Kuhn L, Lopus T, Lee A, Krein S,. Peripherally inserted central catheter-related deep vein thrombosis: contemporary patterns and predictors. J Thromb Haemost. 2014; 12 (6): 847-854.
26. Evans RS, Sharp JH, Linford LH, et al. Risk of symptomatic DVT associated with peripherally inserted central catheters. Chest. 2010; 138 (4): 803-810.
27. Evans RS, Sharp JH, Linford LH, et al. Reduction of peripherally inserted central catheter-associated DVT. Chest. 2013; 143 (3): 627-633.
28. Kang JR, Li HL, Chen W,. Peripherally inserted central catheter-related deep vein thrombosis: contemporary patterns and predictors: comment. J Thromb Haemost. 2014; 12 (11): 1943-1944.
29. Yap YS, Karapetis C, Lerose S, Iyer S, Koczwara B,. Reducing the risk of peripherally inserted central catheter line complications in the oncology setting. Eur J Cancer Care. 2006; 15 (4): 342-347.
30. Guyatt GH, Akl EA, Crowther M, et al. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012; 141 (suppl 2): 7S-47S.
31. Kovacs MJ, Kahn SR, Rodger M, et al. A pilot study of central venous catheter survival in cancer patients using low-molecular-weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study). J Thromb Haemost. 2007; 5 (8): 1650-1653.
32. Kucher N,. Clinical practice. Deep-vein thrombosis of the upper extremities. N Engl J Med. 2011; 364 (9): 861-869.
33. Jones MA, Lee DY, Segall JA, et al. Characterizing resolution of catheter-associated upper extremity deep venous thrombosis. J Vasc Surg. 2010; 51 (1): 108-113.
34. Schiffer CA, Mangu PB, Wade JC, et al. Central venous catheter care for the patient with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2013; 31 (10): 1357-1370.
35. Nash EF, Helm EJ, Stephenson A, Tullis E,. Incidence of deep vein thrombosis associated with peripherally inserted central catheters in adults with cystic fibrosis. J Vasc Interv Radiol. 2009; 20 (3): 347-351.
36. Debourdeau P, Farge D, Beckers M, et al. International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer. J Thromb Haemost. 2013; 11 (1): 71-80.
37. Haas SK, Freund M, Heigener D, et al. Low-molecular-weight heparin versus placebo for the prevention of venous thromboembolism in metastatic breast cancer or stage III/IV lung cancer. Clin Appl Thromb Hemost. 2012; 18 (2): 159-165.